Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancer Research|August 1, 1993
Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reactionJ E Hardingham, D Kotasek, B Farmer, et al.
British Journal of Cancer|April 8, 2010
Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KITD Handolias, A L Hamilton, R Salemi, et al.
International Journal of Cancer|March 17, 2000
Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel diseaseJ E Hardingham, P J Hewett, R E Sage, et al.
The British Journal of Dermatology|March 11, 2015
The role of BRAF mutations in primary melanoma growth rate and survivalV J Mar, W Liu, B Devitt, et al.
Gut|July 11, 1998
Somatic mutations, acetylator status, and prognosis in colorectal cancerJ E Hardingham, W J Butler, D Roder, et al.
Cancer Genetics and Cytogenetics|October 15, 1991
A rare translocation (4;11)(q21;p14-15) in an acute lymphoblastic leukemia expressing T-cell and myeloid markersJ E Hardingham, G B Peters, A Dobrovic, et al.
Familial Cancer|April 25, 2007
Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancerM B Loughrey, P M Waring, A Tan, et al.
Pathology|March 30, 2016
Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutationsT D Clay, P A Russell, H Do, et al.
British Journal of Cancer|December 10, 2014
Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutationsS Deb, S Q Wong, J Li, et al.
Histopathology|July 18, 2006
KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinibM B Loughrey, M Trivett, V Beshay, et al.
Pageof 4